{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T14:12:32Z","timestamp":1788444752864,"version":"build-2803163510"},"reference-count":104,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s00125-026-06795-2","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T12:51:25Z","timestamp":1783947085000},"page":"2659-2671","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dementia in type 2 diabetes: risk factors, disease processes and opportunities for prevention across the lifespan"],"prefix":"10.1007","volume":"69","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4254-8923","authenticated-orcid":false,"given":"Jan F.","family":"de Leijer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6862-2496","authenticated-orcid":false,"given":"Geert Jan","family":"Biessels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3951-5223","authenticated-orcid":false,"given":"Frank L. J.","family":"Visseren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2870-482X","authenticated-orcid":false,"given":"Thomas T.","family":"van Sloten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,13]]},"reference":[{"issue":"2","key":"6795_CR1","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S2213-8587(25)00299-2","volume":"14","author":"I Genitsaridi","year":"2026","unstructured":"Genitsaridi I, Salpea P, Salim A et al (2026) 11th edition of the IDF Diabetes Atlas: global, regional, and national diabetes prevalence estimates for 2024 and projections for 2050. Lancet Diabetes Endocrinol 14(2):149\u2013156. https:\/\/doi.org\/10.1016\/S2213-8587(25)00299-2","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"6795_CR2","doi-asserted-by":"publisher","first-page":"300","DOI":"10.2337\/dc15-1588","volume":"39","author":"S Chatterjee","year":"2016","unstructured":"Chatterjee S, Peters SAE, Woodward M et al (2016) Type 2 diabetes as a risk factor for dementia in women compared with men: A pooled analysis of 2.3 million people comprising more than 100,000 cases of dementia. Diabetes Care 39(2):300\u2013307. https:\/\/doi.org\/10.2337\/dc15-1588","journal-title":"Diabetes Care"},{"issue":"4","key":"6795_CR3","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.3233\/JAD-190427","volume":"71","author":"E Frison","year":"2019","unstructured":"Frison E, Dufouil C, Helmer C et al (2019) Diabetes-associated dementia risk and competing risk of death in the three-city study. J Alzheimer\u2019s Dis 71(4):1339\u20131350. https:\/\/doi.org\/10.3233\/JAD-190427","journal-title":"J Alzheimer\u2019s Dis"},{"issue":"9","key":"6795_CR4","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1093\/aje\/kwae051","volume":"193","author":"E Hayes-Larson","year":"2024","unstructured":"Hayes-Larson E, Zhou Y, Wu Y et al (2024) Heterogeneity in the effect of type 2 diabetes on dementia incidence in a diverse cohort of Asian American and non-Latino White older adults. Am J Epidemiol 193(9):1261\u20131270. https:\/\/doi.org\/10.1093\/aje\/kwae051","journal-title":"Am J Epidemiol"},{"issue":"4","key":"6795_CR5","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.2337\/dc13-0215","volume":"37","author":"ER Mayeda","year":"2014","unstructured":"Mayeda ER, Karter AJ, Huang ES, Moffet HH, Haan MN, Whitmer RA (2014) Racial\/ethnic differences in dementia risk among older type 2 diabetic patients: The diabetes and aging study. Diabetes Care 37(4):1009\u20131015. https:\/\/doi.org\/10.2337\/dc13-0215","journal-title":"Diabetes Care"},{"key":"6795_CR6","doi-asserted-by":"publisher","first-page":"461","DOI":"10.2337\/dc16-1229","volume":"40","author":"MN Munshi","year":"2017","unstructured":"Munshi MN (2017) Cognitive dysfunction in older adults with diabetes: What a clinician needs to know. Diabetes Care 40:461\u2013467. https:\/\/doi.org\/10.2337\/dc16-1229","journal-title":"Diabetes Care"},{"key":"6795_CR7","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s00401-017-1717-7","volume":"134","author":"A Kapasi","year":"2017","unstructured":"Kapasi A, DeCarli C, Schneider JA (2017) Impact of multiple pathologies on the threshold for clinically overt dementia. Acta Neuropathol 134:171\u2013186. https:\/\/doi.org\/10.1007\/s00401-017-1717-7","journal-title":"Acta Neuropathol"},{"key":"6795_CR8","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41583-021-00533-w","volume":"23","author":"GB Frisoni","year":"2022","unstructured":"Frisoni GB, Altomare D, Thal DR et al (2022) The probabilistic model of Alzheimer disease: the amyloid hypothesis revised. Nat Rev Neurosci 23:53\u201366. https:\/\/doi.org\/10.1038\/s41583-021-00533-w","journal-title":"Nat Rev Neurosci"},{"issue":"2","key":"6795_CR9","doi-asserted-by":"publisher","first-page":"539","DOI":"10.3233\/JAD-191192","volume":"76","author":"CR Beam","year":"2020","unstructured":"Beam CR, Kaneshiro C, Jang JY, Reynolds CA, Pedersen NL, Gatz M (2020) A twin study of sex differences in genetic risk for all dementia, Alzheimer\u2019s Disease (AD), and Non-AD Dementia. J Alzheimer\u2019s Dis 76(2):539\u2013551. https:\/\/doi.org\/10.3233\/JAD-191192","journal-title":"J Alzheimer\u2019s Dis"},{"key":"6795_CR10","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1161\/CIRCRESAHA.119.316065","volume":"126","author":"MO Goodarzi","year":"2020","unstructured":"Goodarzi MO, Rotter JI (2020) Genetics insights in the relationship between type 2 diabetes and coronary heart disease. Circ Res 126:1526\u20131548. https:\/\/doi.org\/10.1161\/CIRCRESAHA.119.316065","journal-title":"Circ Res"},{"issue":"11","key":"6795_CR11","doi-asserted-by":"publisher","first-page":"2544","DOI":"10.2337\/dc22-0105","volume":"45","author":"EM Litkowski","year":"2022","unstructured":"Litkowski EM, Logue MW, Zhang R et al (2022) A diabetes genetic risk score is associated with all-cause dementia and clinically diagnosed vascular dementia in the million veteran program. Diabetes Care 45(11):2544\u20132552. https:\/\/doi.org\/10.2337\/dc22-0105","journal-title":"Diabetes Care"},{"key":"6795_CR12","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.mam.2015.06.006","volume":"43\u201344","author":"K Hao","year":"2015","unstructured":"Hao K, Di Narzo AF, Ho L et al (2015) Shared genetic etiology underlying Alzheimer\u2019s disease and type 2 diabetes. Mol Aspects Med 43\u201344:66\u201376. https:\/\/doi.org\/10.1016\/j.mam.2015.06.006","journal-title":"Mol Aspects Med"},{"issue":"11","key":"6795_CR13","doi-asserted-by":"publisher","first-page":"823","DOI":"10.3967\/bes2019.104","volume":"32","author":"DW Chen","year":"2019","unstructured":"Chen DW, Shi JK, Li Y, Yang Y, Ren SP (2019) Association between ApoE polymorphism and type 2 diabetes: a meta-analysis of 59 studies. Biomed Environ Sci 32(11):823\u2013838. https:\/\/doi.org\/10.3967\/bes2019.104","journal-title":"Biomed Environ Sci"},{"issue":"1","key":"6795_CR14","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1001\/archneurol.2007.29","volume":"65","author":"F Irie","year":"2008","unstructured":"Irie F, Fitzpatrick AL, Lopez OL et al (2008) Enhanced risk for Alzheimer disease in persons with type 2 diabetes and APOE \u03b54: the Cardiovascular Health Study Cognition Study. Arch Neurol 65(1):89\u201393. https:\/\/doi.org\/10.1001\/archneurol.2007.29","journal-title":"Arch Neurol"},{"issue":"4","key":"6795_CR15","doi-asserted-by":"publisher","first-page":"100111","DOI":"10.1016\/j.medp.2025.100111","volume":"2","author":"S Yuan","year":"2025","unstructured":"Yuan S, Liu Q, Huang X et al (2025) Age at diabetes diagnosis, genetic susceptibility and dementia risk: a prospective study of 13,126 participants from the UK Biobank. Medicine Plus 2(4):100111. https:\/\/doi.org\/10.1016\/j.medp.2025.100111","journal-title":"Medicine Plus"},{"issue":"1","key":"6795_CR16","doi-asserted-by":"publisher","first-page":"e12006","DOI":"10.1002\/dad2.12006","volume":"12","author":"M Shinohara","year":"2020","unstructured":"Shinohara M, Tashiro Y, Suzuki K, Fukumori A, Bu G, Sato N (2020) Interaction between APOE genotype and diabetes in cognitive decline. Alzheimer\u2019s Dement 12(1):e12006. https:\/\/doi.org\/10.1002\/dad2.12006","journal-title":"Alzheimer\u2019s Dement"},{"issue":"2","key":"6795_CR17","doi-asserted-by":"publisher","first-page":"fcad054","DOI":"10.1093\/braincomms\/fcad054","volume":"5","author":"E Dybjer","year":"2023","unstructured":"Dybjer E, Kumar A, N\u00e4gga K et al (2023) Polygenic risk of type 2 diabetes is associated with incident vascular dementia: a prospective cohort study. Brain Commun 5(2):fcad054. https:\/\/doi.org\/10.1093\/braincomms\/fcad054","journal-title":"Brain Commun"},{"issue":"6","key":"6795_CR18","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1111\/joim.13787","volume":"295","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Gao D, Gao Y et al (2024) Gestational diabetes mellitus is associated with greater incidence of dementia during long-term post-partum follow-up. J Intern Med 295(6):774\u2013784. https:\/\/doi.org\/10.1111\/joim.13787","journal-title":"J Intern Med"},{"issue":"6","key":"6795_CR19","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/S2213-8587(25)00036-1","volume":"13","author":"W Ye","year":"2025","unstructured":"Ye W, Luo C, Zhou J et al (2025) Association between maternal diabetes and neurodevelopmental outcomes in children: a systematic review and meta-analysis of 202 observational studies comprising 56\u00b71 million pregnancies. Lancet Diabetes Endocrinol 13(6):494\u2013504. https:\/\/doi.org\/10.1016\/S2213-8587(25)00036-1","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"23","key":"6795_CR20","doi-asserted-by":"publisher","first-page":"e008870","DOI":"10.1161\/JAHA.118.008870","volume":"7","author":"MR Knop","year":"2018","unstructured":"Knop MR, Geng TT, Gorny AW et al (2018) Birth weight and risk of type 2 diabetes mellitus, cardiovascular disease, and hypertension in adults: a meta-analysis of 7 646 267 participants from 135 studies. J Am Heart Assoc 7(23):e008870. https:\/\/doi.org\/10.1161\/JAHA.118.008870","journal-title":"J Am Heart Assoc"},{"key":"6795_CR21","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1007\/s00127-023-02471-7","volume":"60","author":"AM Wiegersma","year":"2025","unstructured":"Wiegersma AM, Boots A, Langendam MW et al (2025) Do prenatal factors shape the risk for dementia?: A systematic review of the epidemiological evidence for the prenatal origins of dementia. Soc Psychiatry Psychiatr Epidemiol 60:977\u2013991. https:\/\/doi.org\/10.1007\/s00127-023-02471-7","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"6795_CR22","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/S0140-6736(24)01296-0","volume":"404","author":"G Livingston","year":"2024","unstructured":"Livingston G, Huntley J, Liu KY et al (2024) Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission. Lancet 404:572\u2013628. https:\/\/doi.org\/10.1016\/S0140-6736(24)01296-0","journal-title":"Lancet"},{"issue":"1","key":"6795_CR23","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/s41392-024-01951-9","volume":"9","author":"X Lu","year":"2024","unstructured":"Lu X, Xie Q, Pan X et al (2024) Type 2 diabetes mellitus in adults: pathogenesis, prevention and therapy. Signal Transduct Target Ther 9(1):262. https:\/\/doi.org\/10.1038\/s41392-024-01951-9","journal-title":"Signal Transduct Target Ther"},{"issue":"22","key":"6795_CR24","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1001\/jama.298.22.2654","volume":"298","author":"C Willi","year":"2007","unstructured":"Willi C, Bodenmann P, Ghali WA, Faris PD, Cornuz J (2007) Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 298(22):2654\u20132664. https:\/\/doi.org\/10.1001\/jama.298.22.2654","journal-title":"JAMA"},{"issue":"3","key":"6795_CR25","doi-asserted-by":"publisher","first-page":"e0118333","DOI":"10.1371\/journal.pone.0118333","volume":"10","author":"G Zhong","year":"2015","unstructured":"Zhong G, Wang Y, Zhang Y, Guo JJ, Zhao Y (2015) Smoking is associated with an increased risk of dementia: a meta-analysis of prospective cohort studies with investigation of potential effect modifiers. PLoS One 10(3):e0118333. https:\/\/doi.org\/10.1371\/journal.pone.0118333","journal-title":"PLoS One"},{"issue":"2","key":"6795_CR26","doi-asserted-by":"publisher","first-page":"E242","DOI":"10.1212\/WNL.0000000000201419","volume":"100","author":"E Abolhasani","year":"2023","unstructured":"Abolhasani E, Hachinski V, Ghazaleh N, Azarpazhooh MR, Mokhber N, Martin J (2023) Air pollution and incidence of dementia: a systematic review and meta-analysis. Neurology 100(2):E242\u2013E254. https:\/\/doi.org\/10.1212\/WNL.0000000000201419","journal-title":"Neurology"},{"key":"6795_CR27","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s40572-014-0017-9","volume":"1","author":"SK Park","year":"2014","unstructured":"Park SK, Wang W (2014) Ambient air pollution and type 2 diabetes mellitus: a systematic review of epidemiologic research. Curr Environ Health Rep 1:275\u2013286. https:\/\/doi.org\/10.1007\/s40572-014-0017-9","journal-title":"Curr Environ Health Rep"},{"key":"6795_CR28","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1038\/s41591-026-04302-z","volume":"32","author":"A Legaz","year":"2026","unstructured":"Legaz A, Moguilner S, Barttfeld P et al (2026) The exposome of brain aging across 34 countries. Nat Med 32:1838\u20131851. https:\/\/doi.org\/10.1038\/s41591-026-04302-z","journal-title":"Nat Med"},{"issue":"6","key":"6795_CR29","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1001\/jamaneurol.2023.0697","volume":"80","author":"C Moran","year":"2023","unstructured":"Moran C, Lacy ME, Whitmer RA et al (2023) Glycemic control over multiple decades and dementia risk in people with type 2 diabetes. JAMA Neurol 80(6):597\u2013604. https:\/\/doi.org\/10.1001\/jamaneurol.2023.0697","journal-title":"JAMA Neurol"},{"issue":"3","key":"6795_CR30","doi-asserted-by":"publisher","first-page":"634","DOI":"10.2337\/dc21-0601","volume":"45","author":"CA Celis-Morales","year":"2022","unstructured":"Celis-Morales CA, Franz\u00e9en S, Eeg-Olofsson K et al (2022) Type 2 diabetes, glycemic control, and their association with dementia and its major subtypes: findings from the Swedish national diabetes register. Diabetes Care 45(3):634\u2013641. https:\/\/doi.org\/10.2337\/dc21-0601","journal-title":"Diabetes Care"},{"key":"6795_CR31","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1056\/NEJMoa1215740","volume":"369","author":"PK Crane","year":"2013","unstructured":"Crane PK, Walker R, Hubbard RA et al (2013) Glucose levels and risk of dementia. N Engl J Med 369:540\u2013548. https:\/\/doi.org\/10.1056\/NEJMoa1215740","journal-title":"N Engl J Med"},{"issue":"8","key":"6795_CR32","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1007\/s00125-023-05930-7","volume":"66","author":"J Hu","year":"2023","unstructured":"Hu J, Fang M, Pike JR et al (2023) Prediabetes, intervening diabetes and subsequent risk of dementia: the Atherosclerosis Risk in Communities (ARIC) study. Diabetologia 66(8):1442\u20131449. https:\/\/doi.org\/10.1007\/s00125-023-05930-7","journal-title":"Diabetologia"},{"issue":"1","key":"6795_CR33","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13195-020-00758-4","volume":"13","author":"S Hong","year":"2021","unstructured":"Hong S, Han K, Park CY (2021) The insulin resistance by triglyceride glucose index and risk for dementia: population-based study. Alzheimers Res Ther 13(1):9. https:\/\/doi.org\/10.1186\/s13195-020-00758-4","journal-title":"Alzheimers Res Ther"},{"issue":"8","key":"6795_CR34","doi-asserted-by":"publisher","first-page":"5561","DOI":"10.1002\/alz.14066","volume":"20","author":"C Moran","year":"2024","unstructured":"Moran C, Whitmer RA, Dove Z et al (2024) HbA1c variability associated with dementia risk in people with type 2 diabetes. Alzheimer\u2019s Dement 20(8):5561\u20135569. https:\/\/doi.org\/10.1002\/alz.14066","journal-title":"Alzheimer\u2019s Dement"},{"issue":"10","key":"6795_CR35","doi-asserted-by":"publisher","first-page":"4367","DOI":"10.1002\/alz.13373","volume":"19","author":"EM Litkowski","year":"2023","unstructured":"Litkowski EM, Logue MW, Zhang R et al (2023) Mendelian randomization study of diabetes and dementia in the Million Veteran Program. Alzheimer\u2019s Dement 19(10):4367\u20134376. https:\/\/doi.org\/10.1002\/alz.13373","journal-title":"Alzheimer\u2019s Dement"},{"issue":"1","key":"6795_CR36","doi-asserted-by":"publisher","first-page":"9042","DOI":"10.1038\/s41467-025-64927-5","volume":"16","author":"AL Arruda","year":"2025","unstructured":"Arruda AL, Bocher O, Taylor HJ et al (2025) The effect of type 2 diabetes genetic predisposition on non-cardiovascular comorbidities. Nat Commun 16(1):9042. https:\/\/doi.org\/10.1038\/s41467-025-64927-5","journal-title":"Nat Commun"},{"issue":"6","key":"6795_CR37","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1007\/s00125-020-05124-5","volume":"63","author":"M Benn","year":"2020","unstructured":"Benn M, Nordestgaard BG, Tybj\u00e6rg-Hansen A, Frikke-Schmidt R (2020) Impact of glucose on risk of dementia: Mendelian randomisation studies in 115,875 individuals. Diabetologia 63(6):1151\u20131161. https:\/\/doi.org\/10.1007\/s00125-020-05124-5","journal-title":"Diabetologia"},{"issue":"5","key":"6795_CR38","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.3390\/biomedicines13051095","volume":"13","author":"S Han","year":"2025","unstructured":"Han S, Lelieveldt T, Sturkenboom M, Biessels GJ, Ahmadizar F (2025) Evaluating the causal association between type 2 diabetes and Alzheimer\u2019s disease: a two-sample Mendelian randomization study. Biomedicines 13(5):1095. https:\/\/doi.org\/10.3390\/biomedicines13051095","journal-title":"Biomedicines"},{"issue":"3","key":"6795_CR39","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1111\/dom.70353","volume":"28","author":"AC Mason","year":"2026","unstructured":"Mason AC, Fatih N, Sofat R et al (2026) Disentangling the relationship between glucose, insulin and brain health: a UK Biobank study. Diabetes Obes Metab 28(3):1741\u20131749. https:\/\/doi.org\/10.1111\/dom.70353","journal-title":"Diabetes Obes Metab"},{"issue":"9","key":"6795_CR40","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1002\/alz.12320","volume":"17","author":"R Malik","year":"2021","unstructured":"Malik R, Georgakis MK, Neitzel J et al (2021) Midlife vascular risk factors and risk of incident dementia: longitudinal cohort and Mendelian randomization analyses in the UK Biobank. Alzheimer\u2019s Dement 17(9):1422\u20131431. https:\/\/doi.org\/10.1002\/alz.12320","journal-title":"Alzheimer\u2019s Dement"},{"issue":"22","key":"6795_CR41","doi-asserted-by":"publisher","first-page":"22688","DOI":"10.18632\/aging.103887","volume":"12","author":"Y Pan","year":"2020","unstructured":"Pan Y, Chen W, Yan H, Wang M, Xiang X (2020) Glycemic traits and Alzheimer\u2019s disease: a Mendelian randomization study. Aging 12(22):22688\u201322699. https:\/\/doi.org\/10.18632\/aging.103887","journal-title":"Aging"},{"issue":"6","key":"6795_CR42","doi-asserted-by":"publisher","first-page":"e1001841","DOI":"10.1371\/journal.pmed.1001841","volume":"12","author":"SD \u00d8stergaard","year":"2015","unstructured":"\u00d8stergaard SD, Mukherjee S, Sharp SJ et al (2015) Associations between potentially modifiable risk factors and Alzheimer disease: a Mendelian randomization study. PLoS Med 12(6):e1001841. https:\/\/doi.org\/10.1371\/journal.pmed.1001841","journal-title":"PLoS Med"},{"issue":"3","key":"6795_CR43","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1111\/ene.15190","volume":"29","author":"M Zhou","year":"2022","unstructured":"Zhou M, Li H, Wang Y, Pan Y, Wang Y (2022) Causal effect of insulin resistance on small vessel stroke and Alzheimer\u2019s disease: a Mendelian randomization analysis. Eur J Neurol 29(3):698\u2013706. https:\/\/doi.org\/10.1111\/ene.15190","journal-title":"Eur J Neurol"},{"issue":"3","key":"6795_CR44","doi-asserted-by":"publisher","first-page":"371","DOI":"10.2337\/dc24-1699","volume":"48","author":"L Xu","year":"2025","unstructured":"Xu L, Ran J, Shao H et al (2025) Incidence and risk factors of diagnosed young-adult-onset type 2 diabetes in the U.S.: the national health interview survey 2016\u20132022. Diabetes Care 48(3):371\u2013380. https:\/\/doi.org\/10.2337\/dc24-1699","journal-title":"Diabetes Care"},{"key":"6795_CR45","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/j.jacc.2019.07.020","volume":"74","author":"A Wang","year":"2019","unstructured":"Wang A, Green JB, Halperin JL, Piccini JP (2019) Atrial fibrillation and diabetes mellitus: JACC review topic of the week. J Am Coll Cardiol 74:1107\u20131115. https:\/\/doi.org\/10.1016\/j.jacc.2019.07.020","journal-title":"J Am Coll Cardiol"},{"key":"6795_CR46","doi-asserted-by":"publisher","first-page":"E18492","DOI":"10.1097\/MD.0000000000018492","volume":"99","author":"J Li","year":"2020","unstructured":"Li J, Wu Y, Zhang D, Nie J, Onofrj M (2020) Associations between heart failure and risk of dementia: a PRISMA-compliant meta-analysis. Medicine (United States) 99:E18492. https:\/\/doi.org\/10.1097\/MD.0000000000018492","journal-title":"Medicine (United States)"},{"key":"6795_CR47","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s11325-023-02934-w","volume":"28","author":"Q Tian","year":"2024","unstructured":"Tian Q, Sun J, Li X et al (2024) Association between sleep apnoea and risk of cognitive impairment and Alzheimer\u2019s disease: a meta-analysis of cohort-based studies. Sleep Breath 28:585\u2013595. https:\/\/doi.org\/10.1007\/s11325-023-02934-w","journal-title":"Sleep Breath"},{"issue":"1","key":"6795_CR48","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1161\/HYPERTENSIONAHA.120.14993","volume":"76","author":"YN Ou","year":"2020","unstructured":"Ou YN, Tan CC, Shen XN et al (2020) Blood pressure and risks of cognitive impairment and dementia: a systematic review and meta-analysis of 209 prospective studies. Hypertension 76(1):217\u2013225. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.120.14993","journal-title":"Hypertension"},{"issue":"11","key":"6795_CR49","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1016\/j.jalz.2018.02.014","volume":"14","author":"SKL Darweesh","year":"2018","unstructured":"Darweesh SKL, Wolters FJ, Ikram MA, de Wolf F, Bos D, Hofman A (2018) Inflammatory markers and the risk of dementia and Alzheimer\u2019s disease: a meta-analysis. Alzheimer\u2019s Dement 14(11):1450\u20131459. https:\/\/doi.org\/10.1016\/j.jalz.2018.02.014","journal-title":"Alzheimer\u2019s Dement"},{"issue":"9","key":"6795_CR50","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.2337\/dc24-0203","volume":"47","author":"J Hu","year":"2024","unstructured":"Hu J, Pike JR, Lutsey PL et al (2024) Age of diabetes diagnosis and lifetime risk of dementia: the Atherosclerosis Risk in Communities (ARIC) study. Diabetes Care 47(9):1576\u20131583. https:\/\/doi.org\/10.2337\/dc24-0203","journal-title":"Diabetes Care"},{"issue":"16","key":"6795_CR51","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1001\/jama.2021.4001","volume":"325","author":"C BarbielliniAmidei","year":"2021","unstructured":"Barbiellini Amidei C, Fayosse A, Dumurgier J et al (2021) Association between age at diabetes onset and subsequent risk of dementia. JAMA 325(16):1640\u20131649. https:\/\/doi.org\/10.1001\/jama.2021.4001","journal-title":"JAMA"},{"issue":"6","key":"6795_CR52","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1111\/jdi.12087","volume":"4","author":"K Gudala","year":"2013","unstructured":"Gudala K, Bansal D, Schifano F, Bhansali A (2013) Diabetes mellitus and risk of dementia: a meta-analysis of prospective observational studies. J Diabetes Investig 4(6):640\u2013650. https:\/\/doi.org\/10.1111\/jdi.12087","journal-title":"J Diabetes Investig"},{"key":"6795_CR53","doi-asserted-by":"publisher","first-page":"105604","DOI":"10.1016\/j.neubiorev.2024.105604","volume":"159","author":"V van Gils","year":"2024","unstructured":"van Gils V, Rizzo M, C\u00f4t\u00e9 J et al (2024) The association of glucose metabolism measures and diabetes status with Alzheimer\u2019s disease biomarkers of amyloid and tau: a systematic review and meta-analysis. Neurosci Biobehav Rev 159:105604. https:\/\/doi.org\/10.1016\/j.neubiorev.2024.105604","journal-title":"Neurosci Biobehav Rev"},{"issue":"1","key":"6795_CR54","doi-asserted-by":"publisher","first-page":"e12248","DOI":"10.1002\/dad2.12248","volume":"13","author":"K Sadrolashrafi","year":"2021","unstructured":"Sadrolashrafi K, Craft S, Decourt B et al (2021) Is diabetes associated with increased pathological burden in Alzheimer\u2019s disease? Alzheimer\u2019s Dement 13(1):e12248. https:\/\/doi.org\/10.1002\/dad2.12248","journal-title":"Alzheimer\u2019s Dement"},{"issue":"8","key":"6795_CR55","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.jalz.2015.12.006","volume":"12","author":"EL Abner","year":"2016","unstructured":"Abner EL, Nelson PT, Kryscio RJ et al (2016) Diabetes is associated with cerebrovascular but not Alzheimer\u2019s disease neuropathology. Alzheimer\u2019s Dement 12(8):882\u2013889. https:\/\/doi.org\/10.1016\/j.jalz.2015.12.006","journal-title":"Alzheimer\u2019s Dement"},{"issue":"10","key":"6795_CR56","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.2337\/dc24-0162","volume":"47","author":"V van Gils","year":"2024","unstructured":"van Gils V, Tao Q, Ang TFA et al (2024) Associations between glucose metabolism measures and amyloid-\u03b2 and Tau load on PET 14 years later: findings from the Framingham heart study. Diabetes Care 47(10):1787\u20131793. https:\/\/doi.org\/10.2337\/dc24-0162","journal-title":"Diabetes Care"},{"key":"6795_CR57","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack","year":"2018","unstructured":"Jack CR, Bennett DA, Blennow K et al (2018) NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease. Alzheimer\u2019s Dement 14:535\u2013562. https:\/\/doi.org\/10.1016\/j.jalz.2018.02.018","journal-title":"Alzheimer\u2019s Dement"},{"issue":"3","key":"6795_CR58","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1002\/alz.12701","volume":"19","author":"EB Rischel","year":"2023","unstructured":"Rischel EB, Gejl M, Brock B, Rungby J, Gjedde A (2023) In Alzheimer\u2019s disease, amyloid beta accumulation is a protective mechanism that ultimately fails. Alzheimer\u2019s Dement 19(3):771\u2013783. https:\/\/doi.org\/10.1002\/alz.12701","journal-title":"Alzheimer\u2019s Dement"},{"key":"6795_CR59","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/S2213-8587(19)30405-X","volume":"8","author":"TT van Sloten","year":"2020","unstructured":"van Sloten TT, Sedaghat S, Carnethon MR, Launer LJ, Stehouwer CDA (2020) Cerebral microvascular complications of type 2 diabetes: stroke, cognitive dysfunction, and depression. Lancet Diabetes Endocrinol 8:325\u2013336. https:\/\/doi.org\/10.1016\/S2213-8587(19)30405-X","journal-title":"Lancet Diabetes Endocrinol"},{"key":"6795_CR60","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/S1474-4422(20)30139-3","volume":"19","author":"GJ Biessels","year":"2020","unstructured":"Biessels GJ, Nobili F, Teunissen CE, Sim\u00f3 R, Scheltens P (2020) Understanding multifactorial brain changes in type 2 diabetes: a biomarker perspective. Lancet Neurol 19:699\u2013710. https:\/\/doi.org\/10.1016\/S1474-4422(20)30139-3","journal-title":"Lancet Neurol"},{"issue":"9933","key":"6795_CR61","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1016\/S0140-6736(14)60040-4","volume":"383","author":"SAE Peters","year":"2014","unstructured":"Peters SAE, Huxley RR, Woodward M (2014) Diabetes as a risk factor for stroke in women compared with men: a systematic review and meta-analysis of 64 cohorts, including 775 385 individuals and 12 539 strokes. Lancet 383(9933):1973\u20131980. https:\/\/doi.org\/10.1016\/S0140-6736(14)60040-4","journal-title":"Lancet"},{"issue":"4","key":"6795_CR62","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.3233\/JAD-220317","volume":"90","author":"R Waziry","year":"2022","unstructured":"Waziry R, Claus JJ, Hofman A (2022) Dementia risk following ischemic stroke: a systematic review and meta-analysis of factors collected at time of stroke diagnosis. J Alzheimer\u2019s Dis 90(4):1535\u20131546. https:\/\/doi.org\/10.3233\/JAD-220317","journal-title":"J Alzheimer\u2019s Dis"},{"issue":"1","key":"6795_CR63","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13195-025-01708-8","volume":"17","author":"J Kim","year":"2025","unstructured":"Kim J, Han K-D, Lee JY et al (2025) Diabetes status, duration, and risk of dementia among ischemic stroke patients. Alzheimers Res Ther 17(1):58. https:\/\/doi.org\/10.1186\/s13195-025-01708-8","journal-title":"Alzheimers Res Ther"},{"key":"6795_CR64","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/S1474-4422(23)00131-X","volume":"22","author":"M Duering","year":"2023","unstructured":"Duering M, Biessels GJ, Brodtmann A et al (2023) Neuroimaging standards for research into small vessel disease\u2014advances since 2013. Lancet Neurol 22:602\u2013618. https:\/\/doi.org\/10.1016\/S1474-4422(23)00131-X","journal-title":"Lancet Neurol"},{"key":"6795_CR65","doi-asserted-by":"publisher","DOI":"10.1177\/17474930261421046","author":"F Han","year":"2026","unstructured":"Han F, Zhang D-D, Wardlaw JM (2026) Rates and determinants of incident lacunes: a systematic review and meta-analysis. Int J Stroke. https:\/\/doi.org\/10.1177\/17474930261421046","journal-title":"Int J Stroke"},{"issue":"10004","key":"6795_CR66","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1016\/S0140-6736(15)00463-8","volume":"386","author":"JT O\u2019Brien","year":"2015","unstructured":"O\u2019Brien JT, Thomas A (2015) Vascular dementia. Lancet 386(10004):1698\u20131706. https:\/\/doi.org\/10.1016\/S0140-6736(15)00463-8","journal-title":"Lancet"},{"key":"6795_CR67","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/S1474-4422(19)30079-1","volume":"18","author":"JM Wardlaw","year":"2019","unstructured":"Wardlaw JM, Smith C, Dichgans M (2019) Small vessel disease: mechanisms and clinical implications. Lancet Neurol 18:684\u2013696. https:\/\/doi.org\/10.1016\/S1474-4422(19)30079-1","journal-title":"Lancet Neurol"},{"issue":"5","key":"6795_CR68","doi-asserted-by":"publisher","first-page":"e209136","DOI":"10.1212\/WNL.0000000000209136","volume":"102","author":"H Van Den Brink","year":"2024","unstructured":"Van Den Brink H, Pham S, Siero JC et al (2024) Assessment of small vessel function using 7T MRI in patients with sporadic cerebral small vessel disease: the ZOOM@SVDs study. Neurology 102(5):e209136. https:\/\/doi.org\/10.1212\/WNL.0000000000209136","journal-title":"Neurology"},{"issue":"3","key":"6795_CR69","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1210\/jc.2014-2754","volume":"100","author":"PJJ Spauwen","year":"2015","unstructured":"Spauwen PJJ, Van Eupen MGA, K\u00f6hler S et al (2015) Associations of advanced glycation end-products with cognitive functions in individuals with and without type 2 diabetes: the Maastricht study. J Clin Endocrinol Metab 100(3):951\u2013960. https:\/\/doi.org\/10.1210\/jc.2014-2754","journal-title":"J Clin Endocrinol Metab"},{"key":"6795_CR70","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/S1474-4422(20)30231-3","volume":"19","author":"D Kellar","year":"2020","unstructured":"Kellar D, Craft S (2020) Brain insulin resistance in Alzheimer\u2019s disease and related disorders: mechanisms and therapeutic approaches. Lancet Neurol 19:758\u2013766. https:\/\/doi.org\/10.1016\/S1474-4422(20)30231-3","journal-title":"Lancet Neurol"},{"issue":"1","key":"6795_CR71","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1177\/13872877251374353","volume":"108","author":"A Kakkar","year":"2025","unstructured":"Kakkar A, Singh H, Singh BK, Kumar A, Mishra AK, Chopra H (2025) Neuroinflammation and Alzheimer\u2019s disease: unravelling the molecular mechanisms. J Alzheimers Dis 108(1):19\u201341. https:\/\/doi.org\/10.1177\/13872877251374353","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"6795_CR72","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1002\/ana.23956","volume":"74","author":"K Jackson","year":"2013","unstructured":"Jackson K, Barisone GA, Diaz E, Jin LW, DeCarli C, Despa F (2013) Amylin deposition in the brain: a second amyloid in Alzheimer disease? Ann Neurol 74(4):517\u2013526. https:\/\/doi.org\/10.1002\/ana.23956","journal-title":"Ann Neurol"},{"key":"6795_CR73","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00125-024-06104-9","volume":"67","author":"M Heni","year":"2024","unstructured":"Heni M (2024) The insulin resistant brain: impact on whole-body metabolism and body fat distribution. Diabetologia 67:1181\u20131191. https:\/\/doi.org\/10.1007\/s00125-024-06104-9","journal-title":"Diabetologia"},{"key":"6795_CR74","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12974-023-02740-x","volume":"20","author":"M Vargas-Soria","year":"2023","unstructured":"Vargas-Soria M, Garc\u00eda-Alloza M, Corraliza-G\u00f3mez M (2023) Effects of diabetes on microglial physiology: a systematic review of in vitro, preclinical and clinical studies. J Neuroinflammation 20:57. https:\/\/doi.org\/10.1186\/s12974-023-02740-x","journal-title":"J Neuroinflammation"},{"key":"6795_CR75","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1002\/ohn.1346","volume":"173","author":"M Caballero-Borrego","year":"2025","unstructured":"Caballero-Borrego M, Andujar-Lara I (2025) Type 2 diabetes mellitus and hearing loss: a prisma systematic review and meta-analysis. Otolaryngol Head Neck Surg (United States) 173:1041\u20131053. https:\/\/doi.org\/10.1002\/ohn.1346","journal-title":"Otolaryngol Head Neck Surg (United States)"},{"issue":"11","key":"6795_CR76","doi-asserted-by":"publisher","first-page":"7686","DOI":"10.1002\/alz.14236","volume":"20","author":"Y Kim","year":"2024","unstructured":"Kim Y, Stern Y, Seo SW et al (2024) Factors associated with cognitive reserve according to education level. Alzheimer\u2019s Dement 20(11):7686\u20137697. https:\/\/doi.org\/10.1002\/alz.14236","journal-title":"Alzheimer\u2019s Dement"},{"issue":"1","key":"6795_CR77","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1186\/s12889-017-4948-6","volume":"17","author":"S Brinkhues","year":"2017","unstructured":"Brinkhues S, Dukers-Muijrers NHTM, Hoebe CJPA et al (2017) Socially isolated individuals are more prone to have newly diagnosed and prevalent type 2 diabetes mellitus - The Maastricht study. BMC Public Health 17(1):955. https:\/\/doi.org\/10.1186\/s12889-017-4948-6","journal-title":"BMC Public Health"},{"key":"6795_CR78","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1016\/S0140-6736(25)00830-X","volume":"405","author":"A Luk","year":"2025","unstructured":"Luk A, Wild SH, Jones S et al (2025) Early-onset type 2 diabetes: the next major diabetes transition. Lancet 405:2313\u20132326. https:\/\/doi.org\/10.1016\/S0140-6736(25)00830-X","journal-title":"Lancet"},{"issue":"6","key":"6795_CR79","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/S2213-8587(25)00022-1","volume":"13","author":"WC Knowler","year":"2025","unstructured":"Knowler WC, Doherty L, Edelstein SL et al (2025) Long-term effects and effect heterogeneity of lifestyle and metformin interventions on type 2 diabetes incidence over 21 years in the US Diabetes Prevention Program randomised clinical trial. Lancet Diabetes Endocrinol 13(6):469\u2013481. https:\/\/doi.org\/10.1016\/S2213-8587(25)00022-1","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"11","key":"6795_CR80","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.2337\/dc21-0149","volume":"44","author":"ACE van Gennip","year":"2021","unstructured":"van Gennip ACE, Stehouwer CDA, van Boxtel MPJ et al (2021) Association of type 2 diabetes, according to the number of risk factors within target range, with structural brain abnormalities, cognitive performance, and risk of dementia. Diabetes Care 44(11):2493\u20132502. https:\/\/doi.org\/10.2337\/dc21-0149","journal-title":"Diabetes Care"},{"issue":"10","key":"6795_CR81","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.2337\/dc24-0860","volume":"47","author":"A Dove","year":"2024","unstructured":"Dove A, Wang J, Huang H et al (2024) Diabetes, prediabetes, and brain aging: the role of healthy lifestyle. Diabetes Care 47(10):1794\u20131802. https:\/\/doi.org\/10.2337\/dc24-0860","journal-title":"Diabetes Care"},{"issue":"21","key":"6795_CR82","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.1212\/WNL.0000000000003955","volume":"88","author":"MA Espeland","year":"2017","unstructured":"Espeland MA, Luchsinger JA, Baker LD et al (2017) Effect of a long-term intensive lifestyle intervention on prevalence of cognitive impairment. Neurology 88(21):2026\u20132035. https:\/\/doi.org\/10.1212\/WNL.0000000000003955","journal-title":"Neurology"},{"issue":"5","key":"6795_CR83","doi-asserted-by":"publisher","first-page":"764","DOI":"10.2337\/dc15-2230","volume":"39","author":"MA Espeland","year":"2016","unstructured":"Espeland MA, Erickson K, Neiberg RH et al (2016) Brain and white matter hyperintensity volumes after 10 years of random assignment to lifestyle intervention. Diabetes Care 39(5):764\u2013771. https:\/\/doi.org\/10.2337\/dc15-2230","journal-title":"Diabetes Care"},{"issue":"8","key":"6795_CR84","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1001\/jama.2025.12923","volume":"334","author":"LD Baker","year":"2025","unstructured":"Baker LD, Espeland MA, Whitmer RA et al (2025) Structured vs self-guided multidomain lifestyle interventions for global cognitive function. JAMA 334(8):681\u2013691. https:\/\/doi.org\/10.1001\/jama.2025.12923","journal-title":"JAMA"},{"issue":"9984","key":"6795_CR85","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1016\/S0140-6736(15)60461-5","volume":"385","author":"T Ngandu","year":"2015","unstructured":"Ngandu T, Lehtisalo J, Solomon A et al (2015) A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): A randomised controlled trial. Lancet 385(9984):2255\u20132263. https:\/\/doi.org\/10.1016\/S0140-6736(15)60461-5","journal-title":"Lancet"},{"key":"6795_CR86","doi-asserted-by":"publisher","unstructured":"Hafdi M, Hoevenaar-Blom MP, Richard E (2021) Multi-domain interventions for the prevention of dementia and cognitive decline. Cochrane Database Syst Rev 11(11):CD013572. https:\/\/doi.org\/10.1002\/14651858.CD013572.pub2","DOI":"10.1002\/14651858.CD013572.pub2"},{"key":"6795_CR87","doi-asserted-by":"publisher","unstructured":"Areosa Sastre A, Vernooij RWM, Gonz\u00e1lez-Cola\u00e7o Harmand M, Mart\u00ednez G (2017) Effect of the treatment of type 2 diabetes mellitus on the development of cognitive impairment and dementia. Cochrane Database Syst Rev 6(6):CD003804. https:\/\/doi.org\/10.1002\/14651858.CD003804.pub2","DOI":"10.1002\/14651858.CD003804.pub2"},{"key":"6795_CR88","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/S2213-8587(13)70088-3","volume":"2","author":"GJ Biessels","year":"2014","unstructured":"Biessels GJ, Strachan MWJ, Visseren FLJ, Kappelle LJ, Whitmer RA (2014) Dementia and cognitive decline in type 2 diabetes and prediabetic stages: Towards targeted interventions. Lancet Diabetes Endocrinol 2:246\u2013255. https:\/\/doi.org\/10.1016\/S2213-8587(13)70088-3","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"6795_CR89","doi-asserted-by":"publisher","first-page":"331","DOI":"10.2337\/dc22-1496","volume":"46","author":"W Alkabbani","year":"2023","unstructured":"Alkabbani W, Maxwell CJ, Marrie RA, Tyas SL, Lega IC, Gamble JM (2023) Associations of mid-and late-life severe hypoglycemic episodes with incident dementia among patients with type 2 diabetes: a population-based cohort study. Diabetes Care 46(2):331\u2013340. https:\/\/doi.org\/10.2337\/dc22-1496","journal-title":"Diabetes Care"},{"issue":"2","key":"6795_CR90","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/dom.15331","volume":"26","author":"A KuateDefo","year":"2024","unstructured":"Kuate Defo A, Bakula V, Pisaturo A, Labos C, Wing SS, Daskalopoulou SS (2024) Diabetes, antidiabetic medications and risk of dementia: a systematic umbrella review and meta-analysis. Diabetes Obes Metab 26(2):441\u2013462. https:\/\/doi.org\/10.1111\/dom.15331","journal-title":"Diabetes Obes Metab"},{"issue":"2","key":"6795_CR91","doi-asserted-by":"publisher","first-page":"297","DOI":"10.2337\/dc22-1705","volume":"46","author":"CY Wu","year":"2023","unstructured":"Wu CY, Iskander C, Wang C et al (2023) Association of sodium-glucose cotransporter 2 inhibitors with time to dementia: a population-based cohort study. Diabetes Care 46(2):297\u2013304. https:\/\/doi.org\/10.2337\/dc22-1705","journal-title":"Diabetes Care"},{"issue":"8","key":"6795_CR92","doi-asserted-by":"publisher","first-page":"e209805","DOI":"10.1212\/WNL.0000000000209805","volume":"103","author":"HK Kim","year":"2024","unstructured":"Kim HK, Biessels GJ, Yu MH et al (2024) SGLT2 inhibitor use and risk of dementia and Parkinson disease among patients with type 2 diabetes. Neurology 103(8):e209805. https:\/\/doi.org\/10.1212\/WNL.0000000000209805","journal-title":"Neurology"},{"issue":"7","key":"6795_CR93","doi-asserted-by":"publisher","first-page":"e2521016","DOI":"10.1001\/jamanetworkopen.2025.21016","volume":"8","author":"HT Lin","year":"2025","unstructured":"Lin HT, Tsai YF, Liao PL, Wei JCC (2025) Neurodegeneration and stroke after semaglutide and tirzepatide in patients with diabetes and obesity. JAMA Netw Open 8(7):e2521016. https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.21016","journal-title":"JAMA Netw Open"},{"issue":"7","key":"6795_CR94","doi-asserted-by":"publisher","first-page":"E650","DOI":"10.1212\/WNL.0000000000200771","volume":"99","author":"B Tang","year":"2022","unstructured":"Tang B, Wang Y, Jiang X et al (2022) Genetic variation in targets of antidiabetic drugs and Alzheimer disease risk: a Mendelian randomization study. Neurology 99(7):E650\u2013E659. https:\/\/doi.org\/10.1212\/WNL.0000000000200771","journal-title":"Neurology"},{"key":"6795_CR95","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/S1474-4422(20)30173-3","volume":"19","author":"T Cukierman-Yaffe","year":"2020","unstructured":"Cukierman-Yaffe T, Gerstein HC, Colhoun HM et al (2020) Effect of dulaglutide on cognitive impairment in type 2 diabetes: an exploratory analysis of the REWIND trial. Lancet Neurol 19:582\u2013590. https:\/\/doi.org\/10.1016\/S1474-4422(20)30173-3","journal-title":"Lancet Neurol"},{"issue":"5","key":"6795_CR96","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1001\/jamaneurol.2025.0360","volume":"82","author":"A Seminer","year":"2025","unstructured":"Seminer A, Mulihano A, O\u2019Brien C et al (2025) Cardioprotective glucose-lowering agents and dementia risk: a systematic review and meta-analysis. JAMA Neurol 82(5):450\u2013460. https:\/\/doi.org\/10.1001\/jamaneurol.2025.0360","journal-title":"JAMA Neurol"},{"key":"6795_CR97","doi-asserted-by":"publisher","first-page":"S266","DOI":"10.2337\/dc25-S013","volume":"48","author":"American Diabetes Association Professional Practice Committee","year":"2025","unstructured":"American Diabetes Association Professional Practice Committee (2025) 13. Older adults: standards of care in diabetes\u20142025. Diabetes Care 48:S266\u2013S282. https:\/\/doi.org\/10.2337\/dc25-S013","journal-title":"Diabetes Care"},{"key":"6795_CR98","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00125-019-04977-9","volume":"63","author":"GJ Biessels","year":"2020","unstructured":"Biessels GJ, Whitmer RA (2020) Cognitive dysfunction in diabetes: how to implement emerging guidelines. Diabetologia 63:3\u20139. https:\/\/doi.org\/10.1007\/s00125-019-04977-9","journal-title":"Diabetologia"},{"issue":"3","key":"6795_CR99","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S2213-8587(13)70048-2","volume":"1","author":"LG Exalto","year":"2013","unstructured":"Exalto LG, Biessels GJ, Karter AJ et al (2013) Risk score for prediction of 10 year dementia risk in individuals with type 2 diabetes: a cohort study. Lancet Diabetes Endocrinol 1(3):183\u2013190. https:\/\/doi.org\/10.1016\/S2213-8587(13)70048-2","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"6795_CR100","doi-asserted-by":"publisher","first-page":"423","DOI":"10.3233\/JAD-150466","volume":"49","author":"HB Mehta","year":"2015","unstructured":"Mehta HB, Mehta V, Tsai CL, Chen H, Aparasu RR, Johnson ML (2015) Development and validation of the RxDx-dementia risk index to predict dementia in patients with type 2 diabetes and hypertension. J Alzheimer\u2019s Dis 49(2):423\u2013432. https:\/\/doi.org\/10.3233\/JAD-150466","journal-title":"J Alzheimer\u2019s Dis"},{"issue":"7","key":"6795_CR101","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1111\/ene.13642","volume":"25","author":"CI Li","year":"2018","unstructured":"Li CI, Li TC, Liu CS et al (2018) Risk score prediction model for dementia in patients with type 2 diabetes. Eur J Neurol 25(7):976\u2013983. https:\/\/doi.org\/10.1111\/ene.13642","journal-title":"Eur J Neurol"},{"issue":"1","key":"6795_CR102","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/s41591-025-04106-7","volume":"32","author":"P Edison","year":"2026","unstructured":"Edison P, Femminella GD, Ritchie C et al (2026) Liraglutide in mild to moderate Alzheimer\u2019s disease: a phase 2b clinical trial. Nat Med 32(1):353\u2013361. https:\/\/doi.org\/10.1038\/s41591-025-04106-7","journal-title":"Nat Med"},{"issue":"10544","key":"6795_CR103","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1016\/S0140-6736(26)00459-9","volume":"407","author":"JL Cummings","year":"2026","unstructured":"Cummings JL, Atri A, Sano M et al (2026) Efficacy and safety of oral semaglutide 14 mg (flexible dose) in early-stage symptomatic Alzheimer\u2019s disease (EVOKE and EVOKE+): two phase 3, randomised, placebo-controlled trials. Lancet 407(10544):2167\u20132179. https:\/\/doi.org\/10.1016\/S0140-6736(26)00459-9","journal-title":"Lancet"},{"key":"6795_CR104","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41574-018-0048-7","volume":"14","author":"GJ Biessels","year":"2018","unstructured":"Biessels GJ, Despa F (2018) Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications. Nat Rev Endocrinol 14:591\u2013604. https:\/\/doi.org\/10.1038\/s41574-018-0048-7","journal-title":"Nat Rev Endocrinol"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-026-06795-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00125-026-06795-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-026-06795-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T13:16:26Z","timestamp":1788441386000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00125-026-06795-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,13]]},"references-count":104,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["6795"],"URL":"https:\/\/doi.org\/10.1007\/s00125-026-06795-2","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,13]]},"assertion":[{"value":"17 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"JdL and TvS are supported by grants from the European Foundation for the Study of Diabetes (EFSD) and the Dutch Diabetes Association. GJB is supported by the Timely, Accurate, and Personalized Diagnosis of Dementia (TAP-dementia) program, which receives funding from ZonMw (no. 10510032120003).","order":1,"name":"Ethics","label":"Funding","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"GJB consults for Nestl\u00e9 Health Science for the COGNIKET-MCI trial. All financial compensation for these services is transferred to his employer, University Medical Center Utrecht. The other authors declare that there are no relationships or activities that might bias, or be perceived to bias, their work.","order":2,"name":"Ethics","label":"Authors\u2019 relationships and activities","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All authors were responsible for drafting the article and reviewing it critically for important intellectual content. All authors approved the final version to be published.","order":3,"name":"Ethics","label":"Contribution statement","group":{"name":"EthicsHeading","label":"Ethics"}}]}}